{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:16:54Z","timestamp":1768918614280,"version":"3.49.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.2217\/fca.12.5","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T15:45:56Z","timestamp":1331826356000},"page":"371-382","source":"Crossref","is-referenced-by-count":41,"title":["The REG1 Anticoagulation System: A Novel Actively Controlled Factor Ix Inhibitor Using RNA Aptamer Technology for Treatment of Acute Coronary Syndrome"],"prefix":"10.1080","volume":"8","author":[{"given":"John Paul","family":"Vavalle","sequence":"first","affiliation":[{"name":"Duke University Medical Center\rDurham\rNC\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio G","family":"Cohen","sequence":"additional","affiliation":[{"name":"Cardiovascular Division University of Miami Miller School of Medicine 1400 N.W. 12th Avenue Room 1179\rMiami\rFL\r33136\rUSA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,5,29]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.576S"},{"issue":"9","key":"e_1_3_2_3_2_1","first-page":"e82","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).","volume":"110","author":"Antman EM","year":"2004","unstructured":"Antman EM , AnbeDT, ArmstrongPWet al. ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation , 110(9), e82\u2013e292 (2004).","journal-title":"Circulation"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.170815"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.013"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00485-8"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00972-X"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/502114"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.056"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.02.011"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.13.1555"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062437"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708191"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.7.853"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055443"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.joc60038"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.24.2994"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.20.2594"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052711"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000259363.91070.f1"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99165-9"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01236.x"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115495"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199709000-00036"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/hq0302.105375"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(98)00437-1"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614852"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.1.91"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(98)70419-2"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2200121"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1857967"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.43.25702"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-12-0790"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945011794182674"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.668434"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.745687"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02932.x"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.927756"},{"issue":"5","key":"e_1_3_2_3_38_1","first-page":"378","volume":"27","author":"Becker RC","year":"2007","unstructured":"Becker RC , OneyS, BeckerKC, RusconiCP, SullengerB. Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapy. Hamostaseologie, 27(5), 378\u2013382 (2007).","journal-title":"Hamostaseologie"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00963"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-011-0588-3"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr179"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"crossref","unstructured":"Povsic TJ VavalleJP KasprzakJDet al. A randomized partially-blinded multi-center active-controlled dose-ranging study assessing the safety efficacy and pharmacodynamics of the REG1 anticoagulation system compared with unfractionated heparin or low molecular weight heparin in subjects with acute coronary syndromes: primary results of the RADAR randomized clinical trial. Presented at: The 60th Annual Scientific Session of the American College of Cardiology. New Orleans LA USA 2\u20135 April 2011.","DOI":"10.1016\/j.ahj.2010.10.022"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.10.022"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca.12.5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:29:58Z","timestamp":1715995798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca.12.5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.2217\/fca.12.5"],"URL":"https:\/\/doi.org\/10.2217\/fca.12.5","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}